Pharmaceutical :: Bristol-Myers Squibb Investment is the First to Span Discovery and Development in India
Bristol-Myers Squibb Company (NYSE: BMY) today announced the company is expanding its research and development (R&D) capabilities in India. The increase is an integral part of the company?s overall R&D global strategy of accessing top-talent around the world in support of its goal of achieving sustainable, cost-effective growth.